Education
About Us
Working with TipRanks
Follow Us
Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
AGY Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
8p
Hold
-1.23%
Downside
Reiterated
07/01/25
Allergy Therapeutics has significant financial challenges, which are the most impactful factor on its stock score. However, technical analysis shows some positive momentum, and promising corporate events suggest potential future growth, partially offsetting financial weaknesses. Valuation concerns remain due to negative earnings.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
8p
Hold
-1.23%
Downside
Reiterated
07/01/25
Allergy Therapeutics has significant financial challenges, which are the most impactful factor on its stock score. However, technical analysis shows some positive momentum, and promising corporate events suggest potential future growth, partially offsetting financial weaknesses. Valuation concerns remain due to negative earnings.
AGY Analyst Recommendation Trends
Rating
Jul 22
Oct 22
Nov 22
Jun 25
Jul 25
Strong Buy
3
3
3
2
1
Buy
0
0
0
0
0
Hold
0
0
0
3
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
5
6
Each month's total comprises the sum of three months' worth of ratings.
AGY Stock Forecast FAQ
What is GB:AGY’s average 12-month price target, according to analysts?
Based on analyst ratings, Allergy Therapeutics PLC’s 12-month average price target is 7.50.
What is GB:AGY’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:AGY, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Allergy Therapeutics PLC a Buy, Sell or Hold?
Allergy Therapeutics PLC has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Allergy Therapeutics PLC’s share price target?
The average share price target for Allergy Therapeutics PLC is 7.50. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is 7.50p ,and the lowest forecast is 7.50p. The average share price target represents -7.41% Decrease from the current price of 8.1p.
The highest analyst share price target is 7.50p ,and the lowest forecast is 7.50p. The average share price target represents -7.41% Decrease from the current price of 8.1p.
What do analysts say about Allergy Therapeutics PLC?
Allergy Therapeutics PLC’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Allergy Therapeutics PLC?
To buy shares of GB:AGY, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.